/
Finerenone in CKD and Type 2 Diabetes: The FIDELIO-DKD Trial
AI Generated
Save to my account
Sign up
Report Bug
Finerenone in CKD and Type 2 Diabetes: The FIDELIO-DKD Trial
Your browser does not support the video tag.
0:00 / 5:07
Chapters
Summary
Transcript
Chapters
1
Introduction
0:00
2
Mechanism and Rationale
0:38
3
Trial Design and Participants
1:19
4
Baseline Patient Profile
1:59
5
Primary Kidney Outcomes
2:34
6
Secondary Cardiovascular Benefits
3:13
7
Safety and Hyperkalemia Profile
3:50
8
Clinical Significance
4:32
